Exir Gene Pharmed continued its scientific engagement with the international gene and cell therapy community at the 2026 Annual Meeting of the American Society of Gene & Cell Therapy (ASGCT), held in Boston in May 2026.
Three abstracts involving members of our team (Dr. Vahid Mansouri and Dr. Maryam Bemanalizadeh) were accepted and presented during the meeting, reflecting our continued research activities in gene therapy and translational science.
Presenting at ASGCT provides an important platform for sharing emerging research, exchanging ideas with scientists and clinicians from around the world, and following developments across rapidly evolving areas of gene and cell therapy.
We are pleased to see the scientific work of our team represented once again at one of the field’s major international meetings and look forward to continuing to contribute to the broader gene therapy community.
